| Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial FIELD Study Investigators The Lancet 366 (9500), 1849-1861, 2005 | 4221 | 2005 |
| Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group New England Journal of Medicine 339 (19), 1349-1357, 1998 | 2520 | 1998 |
| Health benefits of herbs and spices: the past, the present, the future L Tapsell, I Hemphill, L Cobiac, DR Sullivan, M Fenech, C Patch, ... University of Wollongong, 2006 | 1669 | 2006 |
| PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial FJ Raal, EA Stein, R Dufour, T Turner, F Civeira, L Burgess, G Langslet, ... The Lancet 385 (9965), 331-340, 2015 | 934 | 2015 |
| Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab E Stroes, D Colquhoun, D Sullivan, F Civeira, RS Rosenson, GF Watts, ... Journal of the American College of Cardiology 63 (23), 2541-2548, 2014 | 718 | 2014 |
| Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial D Sullivan, AG Olsson, R Scott, JB Kim, A Xue, V Gebski, SM Wasserman, ... Jama 308 (23), 2497-2506, 2012 | 647 | 2012 |
| Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... International journal of cardiology 171 (3), 309-325, 2014 | 604 | 2014 |
| Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. TA Sanders, DR Sullivan, J Reeve, GR Thompson Arteriosclerosis: An Official Journal of the American Heart Association, Inc …, 1985 | 430 | 1985 |
| A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors DR Sullivan, TH Marwick, SB Freedman American heart journal 119 (6), 1262-1267, 1990 | 407 | 1990 |
| Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study TME Davis, R Ting, JD Best, MW Donoghoe, PL Drury, DR Sullivan, ... Diabetologia 54, 280-290, 2011 | 384 | 2011 |
| Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in … RJ Simes, IC Marschner, D Hunt, D Colquhoun, D Sullivan, RAH Stewart, ... Circulation 105 (10), 1162-1169, 2002 | 357 | 2002 |
| Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term … MJ Koren, RP Giugliano, FJ Raal, D Sullivan, M Bolognese, G Langslet, ... Circulation 129 (2), 234-243, 2014 | 336 | 2014 |
| Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis S Kotwal, M Jun, D Sullivan, V Perkovic, B Neal Circulation: Cardiovascular Quality and Outcomes 5 (6), 808-818, 2012 | 306 | 2012 |
| Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study K Vaidya, C Arnott, GJ Martínez, B Ng, S McCormack, DR Sullivan, ... JACC: Cardiovascular Imaging 11 (2 Part 2), 305-316, 2018 | 293 | 2018 |
| Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus ZH Alshehry, PA Mundra, CK Barlow, NA Mellett, G Wong, MJ McConville, ... Circulation 134 (21), 1637-1650, 2016 | 275 | 2016 |
| Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease MR Adams, R McCredie, W Jessup, J Robinson, D Sullivan, ... Atherosclerosis 129 (2), 261-269, 1997 | 271 | 1997 |
| Familial hypercholesterolaemia: a model of care for Australasia GF Watts, DR Sullivan, N Poplawski, F Van Bockxmeer, I Hamilton-Craig, ... Atherosclerosis Supplements 12 (2), 221-263, 2011 | 269 | 2011 |
| Development and validation of a ceramide-and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients M Hilvo, PJ Meikle, ER Pedersen, GS Tell, I Dhar, H Brenner, B Schöttker, ... European heart journal 41 (3), 371-380, 2020 | 262 | 2020 |
| A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia A Dart, G Jerums, G Nicholson, M d'Emden, I Hamilton-Craig, G Tallis, ... The American journal of cardiology 80 (1), 39-44, 1997 | 261 | 1997 |
| Levels and changes of HDL cholesterol and apolipoprotein AI in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis SM Boekholdt, BJ Arsenault, GK Hovingh, S Mora, TR Pedersen, ... Circulation 128 (14), 1504-1512, 2013 | 255 | 2013 |
